TY - JOUR
T1 - Journey into tomorrow
T2 - cardiovascular wellbeing transformed by nano-scale innovations
AU - Safhi, Awaji Y.
AU - Albariqi, Ahmed H.
AU - Sabei, Fahad Y.
AU - Alsalhi, Abdullah
AU - Khalil, Fatma Mohamed Ameen
AU - Waheed, Abdul
AU - Arbi, Fawad Mueen
AU - White, Alexandra
AU - Anthony, Stefan
AU - Alissa, Mohammed
N1 - Publisher Copyright:
© 2024
PY - 2024/4
Y1 - 2024/4
N2 - Worldwide, cardiovascular diseases (CVDs) account for the vast majority of deaths and place enormous financial strains on healthcare systems. Gold nanoparticles, quantum dots, polymeric nanoparticles, carbon nanotubes, and lipids are innovative nanomaterials promising in tackling CVDs. In the setting of CVDs, these nanomaterials actively impact cellular responses due to their distinctive properties, including surface energy and topographies. Opportunities to more precisely target CVDs have arisen due to recent developments in nanomaterial science, which have introduced fresh approaches. An in-depth familiarity with the illness and its targeted mechanisms is necessary to use nanomaterials in CVDs effectively. We support the academic community's efforts to prioritize Nano-technological techniques in addressing risk factors linked with cardiovascular diseases, acknowledging the far-reaching effects of these conditions. The significant impact of nanotechnology on the early detection and treatment of cardiovascular diseases highlights the critical need for novel approaches to this pressing health problem, which is affecting people worldwide.
AB - Worldwide, cardiovascular diseases (CVDs) account for the vast majority of deaths and place enormous financial strains on healthcare systems. Gold nanoparticles, quantum dots, polymeric nanoparticles, carbon nanotubes, and lipids are innovative nanomaterials promising in tackling CVDs. In the setting of CVDs, these nanomaterials actively impact cellular responses due to their distinctive properties, including surface energy and topographies. Opportunities to more precisely target CVDs have arisen due to recent developments in nanomaterial science, which have introduced fresh approaches. An in-depth familiarity with the illness and its targeted mechanisms is necessary to use nanomaterials in CVDs effectively. We support the academic community's efforts to prioritize Nano-technological techniques in addressing risk factors linked with cardiovascular diseases, acknowledging the far-reaching effects of these conditions. The significant impact of nanotechnology on the early detection and treatment of cardiovascular diseases highlights the critical need for novel approaches to this pressing health problem, which is affecting people worldwide.
KW - Cardiovascular diseases
KW - Diagnosis
KW - Nanotechnology
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85185519842&partnerID=8YFLogxK
U2 - 10.1016/j.cpcardiol.2024.102428
DO - 10.1016/j.cpcardiol.2024.102428
M3 - Review article
C2 - 38311274
AN - SCOPUS:85185519842
SN - 0146-2806
VL - 49
JO - Current Problems in Cardiology
JF - Current Problems in Cardiology
IS - 4
M1 - 102428
ER -